Avoid Mix-Ups With the New Migraine Meds Ubrelvy and Reyvow

Ubrelvy (yoo-BREL-vee, ubrogepant) and Reyvow (RAY-vow, lasmiditan) will be new oral meds to treat acute migraine in adults.

Expect them to be saved for when patients don't respond to, or can't take, triptans (sumatriptan, etc).

Ubrelvy is the first med in a new drug class called "gepants."

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote